TY - JOUR
T1 - Analysis of motor dysfunction in Down Syndrome reveals motor neuron degeneration
AU - Watson-Scales, Sheona
AU - Kalmar, Bernadett
AU - Lana-Elola, Eva
AU - Gibbins, Dorota
AU - La Russa, Federica
AU - Wiseman, Frances
AU - Williamson, Matthew
AU - Saccon, Rachele
AU - Slender, Amy
AU - Olerinyova, Anna
AU - Mahmood, Radma
AU - Nye, Emma
AU - Cater, Heather
AU - Wells, Sara
AU - Yu, Y. Eugene
AU - Bennett, David L.H.
AU - Greensmith, Linda
AU - Fisher, Elizabeth M.C.
AU - Tybulewicz, Victor L.J.
PY - 2018/5/10
Y1 - 2018/5/10
N2 - Down Syndrome (DS) is caused by trisomy of chromosome 21 (Hsa21) and results in a spectrum of phenotypes including learning and memory deficits, and motor dysfunction. It has been hypothesized that an additional copy of a few Hsa21 dosage-sensitive genes causes these phenotypes, but this has been challenged by observations that aneuploidy can cause phenotypes by the mass action of large numbers of genes, with undetectable contributions from individual sequences. The motor abnormalities in DS are relatively understudied—the identity of causative dosage-sensitive genes and the mechanism underpinning the phenotypes are unknown. Using a panel of mouse strains with duplications of regions of mouse chromosomes orthologous to Hsa21 we show that increased dosage of small numbers of genes causes locomotor dysfunction and, moreover, that the Dyrk1a gene is required in three copies to cause the phenotype. Furthermore, we show for the first time a new DS phenotype: loss of motor neurons both in mouse models and, importantly, in humans with DS, that may contribute to locomotor dysfunction.
AB - Down Syndrome (DS) is caused by trisomy of chromosome 21 (Hsa21) and results in a spectrum of phenotypes including learning and memory deficits, and motor dysfunction. It has been hypothesized that an additional copy of a few Hsa21 dosage-sensitive genes causes these phenotypes, but this has been challenged by observations that aneuploidy can cause phenotypes by the mass action of large numbers of genes, with undetectable contributions from individual sequences. The motor abnormalities in DS are relatively understudied—the identity of causative dosage-sensitive genes and the mechanism underpinning the phenotypes are unknown. Using a panel of mouse strains with duplications of regions of mouse chromosomes orthologous to Hsa21 we show that increased dosage of small numbers of genes causes locomotor dysfunction and, moreover, that the Dyrk1a gene is required in three copies to cause the phenotype. Furthermore, we show for the first time a new DS phenotype: loss of motor neurons both in mouse models and, importantly, in humans with DS, that may contribute to locomotor dysfunction.
UR - http://www.scopus.com/inward/record.url?scp=85048228848&partnerID=8YFLogxK
U2 - 10.1371/journal.pgen.1007383
DO - 10.1371/journal.pgen.1007383
M3 - Article
C2 - 29746474
AN - SCOPUS:85048228848
SN - 1553-7390
VL - 14
JO - PLoS Genetics
JF - PLoS Genetics
IS - 5
M1 - e1007383
ER -